600223.SS
600223.SS
CNE000001147
LUSHANG FREDA PHARMACEUTICAL CO
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
5.93B EUR
6.99B EUR
7.48B EUR
Enterprise Value
3.86B EUR
4.3B EUR
4.72B EUR
Valuation Multiples
Trailing P/E
38.87x
51.75x
48.59x
Forward P/E
27.76x
--
--
Price to Sales
1.57x
2.44x
2.63x
Price to Book
1.39x
1.64x
1.77x
EV/Revenue
1.03x
1.5x
1.66x
EV/EBITDA
15.79x
18.44x
18.39x
Price to FCF (P/FCF)
44.53x
25.49x
43.56x
EV/FCF
29.03x
15.66x
27.5x
FCF Yield
2.25%
3.92%
2.3%
ende